Jonathan Hare
Impact in
- Virology top 5%
- HIV Research and Treatment
-
- HIV/AIDS drug development and treatment
Papers in
- Virology 12
- HIV Research and Treatment 12
-
- HIV/AIDS drug development and treatment 5
- SARS-CoV-2 and COVID-19 Research 4
- Co-authors
- Rachel Rosenthal (2 shared papers)Subramanian Venkatesan (1 shared paper)Nnennaya Kanu (1 shared paper)Charles Swanton (1 shared paper)Reuben S. Harris (1 shared paper)Sergio A. Quezada (1 shared paper)Nicholas McGranahan (1 shared paper)Jiří Bártek (1 shared paper)
- Journals
- Frontiers in Immunology (5 papers)PLoS ONE (2 papers)Frontiers in Pharmacology (1 paper)Frontiers in Public Health (1 paper)PROTEOMICS (1 paper)
- Partner nations
- United StatesUnited KingdomUganda
In The Last Decade
Jonathan Hare
28 papers receiving 325 citations
Peers
Comparison fields: 5 of 74
- Virology 92
- Infectious Diseases 69
- Immunology 59
- Oncology 57
- Genetics 54
Countries citing papers authored by Jonathan Hare
This map shows the geographic impact of Jonathan Hare's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Hare with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Hare more than expected).
Fields of papers citing papers by Jonathan Hare
This network shows the impact of papers produced by Jonathan Hare. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Hare. The network helps show where Jonathan Hare may publish in the future.
Co-authors
The 25 scholars most cited alongside Jonathan Hare, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 109 | |
| 2 | 2019 | 108 | |
| 3 | Effectiveness of an otic product containing miconazole, polymyxin B and prednisolone in the treatment of canine otitis externa: multi-site field trial in the US and Canada. | 2010 | 12 |
| 4 | 2009 | 12 | |
| 5 | 2021 | 10 | |
| 6 | 2024 | 7 | |
| 7 | 2021 | 6 | |
| 8 | 2021 | 6 | |
| 9 | 2018 | 6 | |
| 10 | 2017 | 6 | |
| 11 | 2021 | 4 | |
| 12 | 2021 | 4 | |
| 13 | 2021 | 4 | |
| 14 | 2023 | 4 | |
| 15 | 2022 | 4 | |
| 16 | 2021 | 4 | |
| 17 | Composition of unapproved cannabinoid products directly marketed to Canadian pet owners. | 2020 | 4 |
| 18 | 2022 | 3 | |
| 19 | 2021 | 3 | |
| 20 | In vivo efficacy study of the anti-inflammatory properties of Surolan. | 2006 | 3 |
About Jonathan Hare
Jonathan Hare is a scholar working on Virology, Infectious Diseases, Molecular Biology, Immunology and Small Animals, having authored 32 papers that have together received 330 indexed citations. Recurring topics across this work include HIV Research and Treatment (12 papers), vaccines and immunoinformatics approaches (6 papers), HIV/AIDS drug development and treatment (5 papers), SARS-CoV-2 and COVID-19 Research (4 papers), COVID-19 epidemiological studies (2 papers), T-cell and B-cell Immunology (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Vaccine Coverage and Hesitancy (2 papers). The work is most often cited by research in Virology (92 citations), Infectious Diseases (69 citations), Immunology (59 citations), Oncology (57 citations) and Genetics (54 citations). Jonathan Hare has collaborated with scholars based in United States, United Kingdom and Uganda. Frequent co-authors include Rachel Rosenthal, Subramanian Venkatesan, Nnennaya Kanu, Charles Swanton, Reuben S. Harris, Sergio A. Quezada, Nicholas McGranahan, Jiří Bártek, Jill Gilmour and Philip R. Johnson. Their work appears in journals such as Frontiers in Immunology, PLoS ONE, Frontiers in Pharmacology, Frontiers in Public Health and PROTEOMICS.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.